fep blue glp-1 coverage 2025 KFF on X: "Among the largest employers (with at least 5,000 workers), 43% now cover weight-loss drugs, up from 28% last year. A majority (59%) of those same employers say their GLP-1 Pipeline Update: November 2025

This article is exclusive to STAT+ subscribers Unlock this article plus daily coverage and analysis of the pharma industry by subscribing to STAT+

Reconstituted TB-500 Storage The Freeze-Thaw Problem: Why Aliquoting Matters Every time a frozen peptide solution is thawed and then refrozen, ice crystal formation during the freezing phase causes mechanical disruption to the surrounding solution

Its source of glutathione is also very generic

In December 2025 , the WHO issued its first global guidelines recommending the use of GLP-1 drugs for treating obesity in adults, marking a major shift in international obesity management policy